Skip to main content

Comparative Safety of Sulfonylurea and Metformin Monotherapy on the Risk of Heart Failure: A Cohort Study.


AUTHORS

Roumie CL , Min JY , D'Agostino McGowan L , Presley C , Grijalva CG , Hackstadt AJ , Hung AM , Greevy RA , Elasy T , Griffin MR , . Journal of the American Heart Association. 2017 4 19; 6(4).

ABSTRACT

Medications that impact insulin sensitivity or cause weight gain may increase heart failure risk. Our aim was to compare heart failure and cardiovascular death outcomes among patients initiating sulfonylureas for diabetes mellitus treatment versus metformin.


Medications that impact insulin sensitivity or cause weight gain may increase heart failure risk. Our aim was to compare heart failure and cardiovascular death outcomes among patients initiating sulfonylureas for diabetes mellitus treatment versus metformin.


Tags: